When evaluating the impact of antidepressants on purinergic gene expression, our analysis revealed that ADORA2A levels were significantly reduced in MDD subjects on antidepressants compared to those off-medication, but significantly greater in the off-medication group relative to controls in the superficial gray matter. The gene discussed is ADORA2A; the disease is major depressive disorder.